Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01084252
Brief Title: Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

First Submitted : March 9, 2010
First Submitted that Met QC Criteria : March 9, 2010
First Posted : March 10, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : April 25, 2019
Last Update Posted : April 26, 2019